Shu Yu

1.0k total citations
27 papers, 651 citations indexed

About

Shu Yu is a scholar working on Endocrinology, Infectious Diseases and Immunology. According to data from OpenAlex, Shu Yu has authored 27 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, 8 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Shu Yu's work include Escherichia coli research studies (8 papers), Viral gastroenteritis research and epidemiology (7 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Shu Yu is often cited by papers focused on Escherichia coli research studies (8 papers), Viral gastroenteritis research and epidemiology (7 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Shu Yu collaborates with scholars based in China, Taiwan and United States. Shu Yu's co-authors include Xuhu Mao, Chiu‐Mieh Huang, Weiling Fu, Quanming Zou, Chao Wu, Jiang Gu, Yuan Zhuang, Quanming Zou, Ping Luo and Yun Shi and has published in prestigious journals such as PLoS ONE, FEBS Letters and Heart.

In The Last Decade

Shu Yu

27 papers receiving 643 citations

Peers

Shu Yu

IMMUN

SURGE

ENDOC

Kumiya Sugiyama Japan

Bijay Kumar Jha South Korea

Clemente J. Britto United States

Anders Larsson Sweden

Rebecca F. Taylor United Kingdom

D. Shane O’Mahony United States

William Lynn United Kingdom

Janine Zweigner Germany

Joby Cole United Kingdom

Laurent Favre Switzerland

Kumiya Sugiyama Japan

Shu Yu

137 ×0.8

IMMUN

202 ×1.3

81 ×0.5

SURGE

58 ×0.5

ENDOC

105 ×1.1

Citations per year, relative to Shu Yu Shu Yu (= 1×) peers Kumiya Sugiyama

Countries citing papers authored by Shu Yu

Since Specialization

Citations

This map shows the geographic impact of Shu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Yu more than expected).

Fields of papers citing papers by Shu Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Yu. The network helps show where Shu Yu may publish in the future.

Co-authorship network of co-authors of Shu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Yu. A scholar is included among the top collaborators of Shu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Yu. Shu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Shu, Yueping Liu, Hailiang Liu, et al.. (2017). Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease. Molecular Neurobiology. 55(5). 3999–4008. 19 indexed citations

Wang, Haiguang, Qian Li, Yao Fang, et al.. (2015). Biochemical and functional characterization of the periplasmic domain of the outer membrane protein A from enterohemorrhagic Escherichia coli. Microbiological Research. 182. 109–115. 14 indexed citations

Yu, Shu, Yueping Liu, Yu-Hui Liu, et al.. (2015). Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients. Clinica Chimica Acta. 453. 154–159. 21 indexed citations

Liu, Yue‐Ping, Hanqing Xu, Ming Li, et al.. (2015). Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis. PLoS ONE. 10(12). e0144234–e0144234. 40 indexed citations

Luo, Ping, Xuhu Mao, Li Chen, et al.. (2012). Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: Implications for vaccine design. Vaccine. 30(45). 6449–6455. 10 indexed citations

Yu, Shu, et al.. (2012). Novel Th1-biased adjuvant, SPO1, enhances mucosal and systemic immunogenicity of vaccines administered intranasally in mice. Vaccine. 30(36). 5425–5436. 6 indexed citations

Li, Na, Bin Tang, Endong Zhu, et al.. (2012). Increased miR‐222 in H. pylori‐associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Letters. 586(6). 722–728. 74 indexed citations

Liu, Kaiyun, Yun Shi, Ping Luo, et al.. (2011). Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine. 29(38). 6679–6685. 58 indexed citations

Zhao, Xiaolan, et al.. (2011). Spleen recruits endothelial progenitor cells (EPCs) via SDF-1/CXCR4 axis(*). Heart. 97(Suppl 3). A92.3–A93. 1 indexed citations

10.

Tang, Fu-In, et al.. (2010). Use, Perceived Effectiveness, and Gender Differences of Pain Relief Strategies Among the Community-Dwelling Elderly in Taiwan. Pain Management Nursing. 12(1). 41–49. 15 indexed citations

11.

Zhang, Jinyu, Tao Liu, Hong Guo, et al.. (2010). Induction of a Th17 cell response by Helicobacter pylori Urease subunit B. Immunobiology. 216(7). 803–810. 30 indexed citations

12.

Zhuang, Yuan, Yun Shi, Xiaofei Liu, et al.. (2010). Helicobacter pylori-infected macrophages induce Th17 cell differentiation. Immunobiology. 216(1-2). 200–207. 39 indexed citations

13.

Cheng, Yan, et al.. (2010). EspA is a novel fusion partner for expression of foreign proteins in Escherichia coli. Journal of Biotechnology. 150(3). 380–388. 11 indexed citations

14.

Yu, Shu, Jiang Gu, Haiguang Wang, et al.. (2010). Identification of a novel linear epitope on EspA from enterohemorrhagic E. coli using a neutralizing and protective monoclonal antibody. Clinical Immunology. 138(1). 77–84. 12 indexed citations

15.

Gu, Jiang, Yanqing Liu, Shu Yu, et al.. (2009). Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Microbes and Infection. 11(10-11). 835–841. 36 indexed citations

16.

Cheng, Yan, Youjun Feng, Ping Luo, et al.. (2009). Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development. The Journal of Microbiology. 47(4). 498–505. 25 indexed citations

17.

Ma, Ying, Xuhu Mao, Jun Li, et al.. (2008). Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7. Immunology Letters. 121(2). 110–115. 18 indexed citations

18.

Pang, Yanli, Jirun Peng, Xuewen Pang, et al.. (2008). The immunosuppressive tumor microenvironment in hepatocellular carcinoma. Cancer Immunology Immunotherapy. 58(6). 877–886. 44 indexed citations

19.

Shi, Yun, Ying Ma, Ping Luo, et al.. (2008). Screening and identification of a novel B-cell neutralizing epitope from Helicobacter pylori UreB. Vaccine. 26(52). 6945–6949. 17 indexed citations

20.

Yu, Shu, et al.. (2007). [Preparation and characterization of monoclonal antibody against Enterohemorrhagic Escherichia coli O157:H7 EspA].. PubMed. 23(7). 657–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact